KFF Health News chief Washington correspondent Julie Rovner discussed President-elect Donald Trump’s announcement that he ...

Medicare officials are pushing back against a federal watchdog’s call to crack down on home visits by Medicare Advantage health plans — a practice the watchdog says may waste billions of tax dollars ...

Celebrity doctor Mehmet Oz recently held broad investments in health care, tech, and food companies. Were he confirmed to run ...

On X, a group of interdisciplinary faculty representing Johns Hopkins University shared KFF Health News’ coverage about ...

For nearly 15 years, the feds have had oversight of Georgia’s treatment of people with mental illness and developmental ...

Editorial writers tackle these public health issues.

Although many of President-elect Donald Trump's Cabinet picks have come from the dust jacket of Project 2025, prominent author Roger Severino, a staunch anti-abortionist, has been rejected from ...

Majority Leader Chuck Schumer says the four who were withdrawn from consideration didn't have the votes to get confirmed. However, the Senate Judiciary Committee on Thursday advanced the nominations ...

Possible Reasons For Fewer Fatal Opioid ODs: Less-Potent Pills, Xylazine Tests on the nation's illicit pill supply have shown that, compared to last year, fewer pills have lethal doses of fentanyl.

Meanwhile, cannabis progress could stop under the Trump administration; a labeling issues prompts a recall of the popular drug Clonazepam; Novartis acquires Kate Therapeutics; and more. The Hill: FDA ...

Post-pandemic operating margins remain low. With the National Institutes of Health — a major source of grant funding — facing an uncertain future under the incoming administration, nonprofit health ...

Longer Looks: Interesting Reads You Might Have Missed Each week, KFF Health News finds longer stories for you to enjoy. Today's selections are on vaccines, food additives, addiction, dermatology, and ...